High-sensitivity point-of-care measurement of cardiac troponin . . . New technologies enabling access to high-sensitivity cardiac troponin (hs-cTn) assays at the point of care (POC) are available for routine use POC technology can accelerate cardiac troponin testing within the hospital setting and support testing in other healthcare environments
i-STAT hs-TnI Cartridge | Abbott Point of Care Incorporating the i-STAT hs-TnI test early in the patient experience can accelerate assessments of suspected myocardial infarction (MI), thereby improving triage efficiency High Sensitivity cardiac troponin is recommended by ACC AHA guidelines 1 as the preferred biomarker for detecting MI
Point of care testing for high-sensitive troponin measurement . . . We are writing to share our insights and experiences with the evaluation of the Atellica VTLi ® (Siemens Healthineers) Point of Care Testing (POCT) system for high-sensitive troponin I (HsTnI) measurement at Cliniques Universitaires Saint-Luc (CUSL) in Brussels, Belgium
A New Paradigm for Value: Point-of-care Testing for High-sensitivity . . . A New Paradigm for Value: Point-of-care Testing for High-sensitivity Troponin I Speed meets accuracy where it matters most―the wait is over for hs-cTnI at the point of care When ruling out a potential myocardial infarction (MI), every minute spent waiting on test results comes at a cost
Point-of-care testing with high-sensitivity cardiac troponin assays . . . This manuscript evaluates the point-of-care (POC) testing of cardiac troponin (cTn) including new high-sensitivity (hs) assays, highlights current clinical assessment practices for patients with possible acute coronary syndromes (ACS) and forecasts future opportunities with use of such assays
Analytical and Clinical Performance of High-Sensitivity Cardiac . . . Acute coronary syndrome (ACS) poses a significant burden worldwide; however, the development of high-sensitivity cardiac troponin (hs-cTn) assays has greatly improved patient management by enabling the detection of very low levels of troponin
High-Sensitivity Cardiac Troponin (hs-cTnI) POCT Chemiluminescence . . . I Clinical Status of High-Sensitivity Cardiac Troponin High-sensitivity Cardiac Troponin (hs-cTn) testing currently plays a dominant role in the diagnosis of adult myocardial injury Driven by continuous advancements in detection technology, the FDA first approved hs-cTnI assays in 2017